Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Clinical trial NCT00852540 · COMPLETED

Trial details

NCT number: NCT00852540
Sponsor: Stiefel, a GSK Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Infections, Bacterial

Start date: 2009-04-01
Primary completion: 2010-07-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.